Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS …[85 authors] … Thompson SG, Danesh J. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015 Jul;314(1):52-60.
Interleukin 1 Genetics Consortium, Freitag DF, Butterworth AS, Willeit P, Howson JMM, Burgess S, Kaptoge S, Young R, Ho WK, Wood AM, Sweeting M, Spackman S, Staley JR, Ramond A, Harshfield E …[132 authors] … Di Angelantonio E, Chowdhury R, Nordestgaard BG, Saleheen D, Thompson SG, Danesh J. Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2015 Apr;3(4):243-53.
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 Jan;385(9963):117–71.
Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: one-year outcomes from the IMPROVE randomized trial. European Heart Journal. 2015 Aug 14;36(31):2061–9.
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. The Lancet Diabetes & Endocrinology. 2015 Apr;3(4):243–53.
Zhang C, Doherty JA, Burgess S, Hung RJ, Lindström S, Kraft P, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Human Molecular Genetics. 2015 Sep 15;24(18):5356–66.
Zhang B, Shu X-O, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, et al. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Journal of the National Cancer Institute. 2015 Nov;107(11):djv219.
Ye Z, Sharp SJ, Burgess S, Scott RA, Imamura F, Langenberg C, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes & Endocrinology. 2015 Jan;3(1):35–42.
Wood AM, Royston P, White IR. The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data: The estimation and use of predictions for the assessment. Biometrical Journal. 2015 Jul;57(4):614–32.
Willeit P, Freitag DF, Laukkanen JA, Chowdhury S, Gobin R, Mayr M, et al. Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies. Journal of the American Heart Association. 2015 May 28;4(6):e001833–e001833.
White IR, Wood AM. Statistical Challenges in Risk Prediction: Editorial. Biometrical Journal. 2015 Jul;57(4):529–30.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 Aug;386(9995):743–800.
Turner RM, Jackson D, Wei Y, Thompson SG, Higgins JPT. Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis: R. M. TURNER ET AL. Statistics in Medicine. 2015 Mar 15;34(6):984–98.
Thompson SG, Willeit P. UK Biobank comes of age. The Lancet. 2015 Aug;386(9993):509–10.
The LifeLines Cohort Study, The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GLGC, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015 Feb;518(7538):197–206.
The EPIC-InterAct Consortium, Wessel J, Chu AY, Willems SM, Wang S, Yaghootkar H, et al. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nature Communications [Internet]. 2015 Dec [cited 2018 Jun 22];6(1). Available from: http://www.nature.com/articles/ncomms6897
The Coffee and Caffeine Genetics Consortium, International Parkinson’s Disease Genomics Consortium (IPDGC), North American Brain Expression Consortium (NABEC), UK Brain Expression Consortium (UKBEC), Cornelis MC, Byrne EM, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Molecular Psychiatry. 2015 May;20(5):647–56.
the CARDIoGRAMplusC4D Consortium, Nikpay M, Goel A, Won H-H, Hall LM, Willenborg C, et al. A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease. Nature Genetics. 2015 Oct;47(10):1121–30.
The ADIPOGen Consortium, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The GLGC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015 Feb;518(7538):187–96.
Sweeting MJ, Ulug P, Powell JT, Desgranges P, Balm R. Ruptured Aneurysm Trials: The Importance of Longer-term Outcomes and Meta-analysis for 1-year Mortality. European Journal of Vascular and Endovascular Surgery. 2015 Sep;50(3):297–302.
Sweeting MJ, Balm R, Desgranges P, Ulug P, Powell JT, Ruptured Aneurysm Trialists. Individual-patient meta-analysis of three randomized trials comparing endovascular versus open repair for ruptured abdominal aortic aneurysm: Endovascular versus open repair strategies for ruptured abdominal aortic aneurysm. British Journal of Surgery. 2015 Sep;102(10):1229–39.
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLOS Medicine. 2015 Mar 31;12(3):e1001779.
Silarova B, Lucas J, Butterworth AS, Di Angelantonio E, Girling C, Lawrence K, et al. Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour. BMC Public Health [Internet]. 2015 Dec [cited 2018 Jun 22];15(1). Available from: http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-2192-5
Rubbo B, Fitzpatrick NK, Denaxas S, Daskalopoulou M, Yu N, Patel RS, et al. Use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: A systematic review and recommendations. International Journal of Cardiology. 2015 May;187:705–11.
Pirie A, Wood A, Lush M, Tyrer J, Pharoah PD. The effect of rare variants on inflation of the test statistics in case–control analyses. BMC Bioinformatics [Internet]. 2015 Dec [cited 2018 Jun 22];16(1). Available from: http://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-015-0496-1
Pennant M, Steur M, Moore C, Butterworth A, Johnson L. Comparative validity of vitamin C and carotenoids as indicators of fruit and vegetable intake: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition. 2015 Nov;114(09):1331–40.
On behalf of the European Vertebral Osteoporosis Study (EVOS) and European Prospective Osteoporosis Study (EPOS) Groups, Armbrecht G, Felsenberg D, Ganswindt M, Lunt M, Kaptoge SK, et al. Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over. Osteoporosis International. 2015 Oct;26(10):2509–19.
Oliver-Williams CT, Steer PJ. Racial variation in the number of spontaneous abortions before a first successful pregnancy, and effects on subsequent pregnancies. International Journal of Gynecology & Obstetrics. 2015 Jun;129(3):207–12.
Oliver-Williams C, Fleming M, Wood A, Smith G. Previous miscarriage and the subsequent risk of preterm birth in Scotland, 1980-2008: a historical cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2015 Oct;122(11):1525–34.
Nolan T, Dack C, Pal K, Ross J, Stevenson FA, Peacock R, et al. Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care. British Journal of General Practice. 2015 Mar 1;65(632):e152–60.
NHLBI Exome Sequencing Project, Do R, Stitziel NO, Won H-H, Jørgensen AB, Duga S, et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature. 2015 Feb;518(7537):102–6.
Newton JN, Briggs ADM, Murray CJL, Dicker D, Foreman KJ, Wang H, et al. Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 Dec;386(10010):2257–74.
Nelson CP, Hamby SE, Saleheen D, Hopewell JC, Zeng L, Assimes TL, et al. Genetically Determined Height and Coronary Artery Disease. New England Journal of Medicine. 2015 Apr 23;372(17):1608–18.
Nead KT, Li A, Wehner MR, Neupane B, Gustafsson S, Butterworth A, et al. Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals. Human Molecular Genetics. 2015 Jun 15;24(12):3582–94.
Murray E, Dack C, Barnard M, Farmer A, Li J, Michie S, et al. HeLP-Diabetes: randomised controlled trial protocol. BMC Health Services Research [Internet]. 2015 Jun [cited 2018 Jun 22];15(1). Available from: http://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-015-1246-9
Murray CJL, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015 Nov;386(10009):2145–91.
Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. European Journal of Epidemiology. 2015 Apr;30(4):251–77.
Moraitis A, Oliver-Williams C, Wood A, Fleming M, Pell J, Smith G. Previous caesarean delivery and the risk of unexplained stillbirth: retrospective cohort study and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2015 Oct;122(11):1467–74.
McCloskey EV, Kanis JA, Odén A, Harvey NC, Bauer D, González-Macias J, et al. Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis. Osteoporosis International. 2015 Jul;26(7):1979–87.
Mata DA, Ramos MA, Bansal N, Khan R, Guille C, Di Angelantonio E, et al. Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis. JAMA. 2015 Dec 8;314(22):2373.
Mander AP, Sweeting MJ. A product of independent beta probabilities dose escalation design for dual-agent phase I trials. Statistics in Medicine. 2015 Apr 15;34(8):1261–76.
Lorenz MW, Price JF, Robertson C, Bots ML, Polak JF, Poppert H, et al. Carotid Intima-Media Thickness Progression and Risk of Vascular Events in People With Diabetes: Results From the PROG-IMT Collaboration. Diabetes Care. 2015 Oct;38(10):1921–9.
Leermakers ETM, Moreira EM, Kiefte-de Jong JC, Darweesh SKL, Visser T, Voortman T, et al. Effects of choline on health across the life course: a systematic review. Nutrition Reviews. 2015 Aug;73(8):500–22.
Kunutsor SK, Bakker SJL, Gansevoort RT, Chowdhury R, Dullaart RPF. Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General PopulationSignificance. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015 Mar;35(3):716–24.
Klinck J, McNeill L, Di Angelantonio E, Menon DK. Predictors and outcome impact of perioperative serum sodium changes in a high-risk population. British Journal of Anaesthesia. 2015 Apr;114(4):615–22.
Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Weimar C, Serena J, et al. Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. European Heart Journal. 2015 Sep 14;36(35):2381–9.
Jones E, Sweeting MJ, Sharp SJ, Thompson SG. A method making fewer assumptions gave the most reliable estimates of exposure–outcome associations in stratified case–cohort studies. Journal of Clinical Epidemiology. 2015 Dec;68(12):1397–405.
Jenkins V, Fallowfield L, Langridge C, Barrett J, Ryan A, Jacobs I, et al. Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening: International Journal of Gynecological Cancer. 2015 Oct;25(8):1519–25.
Jaspers L, Colpani V, Chaker L, van der Lee SJ, Muka T, Imo D, et al. The global impact of non-communicable diseases on households and impoverishment: a systematic review. European Journal of Epidemiology. 2015 Mar;30(3):163–88.
IMPROVE Trial Investigators, IMPROVE Trial Investigators, Anjum A, Thompson L, Azhar B, Hughes C, et al. The effect of aortic morphology on peri-operative mortality of ruptured abdominal aortic aneurysm. European Heart Journal. 2015 Jun 1;36(21):1328–34.
Hu X, Deutsch AJ, Lenz TL, Onengut-Gumuscu S, Han B, Chen W-M, et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nature Genetics. 2015 Aug;47(8):898–905.
Harshfield E, Chowdhury R, Harhay MN, Bergquist H, Harhay MO. Association of hypertension and hyperglycaemia with socioeconomic contexts in resource-poor settings: the Bangladesh Demographic and Health Survey. International Journal of Epidemiology. 2015 Oct;44(5):1625–36.
Galesloot TE, Janss LL, Burgess S, Kiemeney LALM, den Heijer M, de Graaf J, et al. Iron and hepcidin as risk factors in atherosclerosis: what do the genes say? BMC Genetics [Internet]. 2015 Dec [cited 2018 Jun 22];16(1). Available from: http://www.biomedcentral.com/1471-2156/16/79
Franco OH, Muka T, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, et al. Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis. Maturitas. 2015 Jul;81(3):353–61.
EPIC- InterAct Consortium, Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. European Journal of Epidemiology. 2015 Jul;30(7):543–52.
Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of Cardiometabolic Multimorbidity With Mortality. JAMA. 2015 Jul 7;314(1):52.
Davies NM, von Hinke Kessler Scholder S, Farbmacher H, Burgess S, Windmeijer F, Smith GD. The many weak instruments problem and Mendelian randomization. Statistics in Medicine. 2015 Feb 10;34(3):454–68.
Cooper NJ, Shtir CJ, Smyth DJ, Guo H, Swafford AD, Zanda M, et al. Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes. Human Molecular Genetics. 2015 Mar 15;24(6):1774–90.
Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. The Lancet Diabetes & Endocrinology. 2015 Jul;3(7):526–34.
Chaker L, Falla A, van der Lee SJ, Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. European Journal of Epidemiology. 2015 May;30(5):357–95.
Cardiology Research Group, Chowdhury R, Alam DS, Fakir II, Adnan SD, Naheed A, et al. The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and design. European Journal of Epidemiology. 2015 Jul;30(7):577–87.
Burgess S, Timpson NJ, Ebrahim S, Davey Smith G. Mendelian randomization: where are we now and where are we going? International Journal of Epidemiology. 2015 Apr 1;44(2):379–88.
Burgess S, Thompson SG. Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects. American Journal of Epidemiology. 2015 Feb 15;181(4):251–60.
Burgess S, Daniel RM, Butterworth AS, Thompson SG, the EPIC-InterAct Consortium. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. International Journal of Epidemiology. 2015 Apr 1;44(2):484–95.
Brill SE, Law M, El-Emir E, Allinson JP, James P, Maddox V, et al. Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial. Thorax. 2015 Oct;70(10):930–8.
Brickley EB, Wood AM, Kabyemela E, Morrison R, Kurtis JD, Fried M, et al. Fetal Origins of Malarial Disease: Cord Blood Cytokines as Risk Markers for Pediatric Severe Malarial Anemia. Journal of Infectious Diseases. 2015 Feb 1;211(3):436–44.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. International Journal of Epidemiology. 2015 Apr 1;44(2):512–25.
BIOS-consortium, CARDIo GRAMplusCD, LifeLines Cohort Study, The InterAct Consortium, Kato N, Loh M, et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nature Genetics. 2015 Nov;47(11):1282–93.
Barrett J, Diggle P, Henderson R, Taylor-Robinson D. Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference. Journal of the Royal Statistical Society: Series B (Statistical Methodology). 2015 Jan;77(1):131–48.
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of Undiagnosed Hypertension in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Hypertension. 2015 Feb 1;65(2):291–8.
AOGC Consortium, UK10K Consortium, Zheng H, Forgetta V, Hsu Y, Estrada K, et al. Whole‐genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature. 2015 Oct;526(7571):112–7.
Anchala R, Kaptoge S, Pant H, Di Angelantonio E, Franco OH, Prabhakaran D. Evaluation of Effectiveness and Cost-Effectiveness of a Clinical Decision Support System in Managing Hypertension in Resource Constrained Primary Health Care Settings: Results From a Cluster Randomized Trial. Journal of the American Heart Association. 2015 Jan 5;4(1):e001213–e001213.
Ahmadi-Abhari S, Kaptoge S, Luben RN, Wareham NJ, Khaw K-T. Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: the European Prospective Investigation into Cancer – Norfolk study. Cardiovascular Diabetology [Internet]. 2015 Dec
[cited 2018 Jun 22];14(1). Available from: http://www.cardiab.com/content/14/1/61Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. The Lancet Diabetes & Endocrinology. 2014 Aug;2(8):634–47.
Wormser D, Wood AM, Di Angelantonio E, Thompson SG, Danesh J. Metabolic mediators of body-mass index and cardiovascular risk. The Lancet. 2014 Jun;383(9934):2042–3.
Willeit P, Raschenberger J, Heydon EE, Tsimikas S, Haun M, Mayr A, et al. Leucocyte Telomere Length and Risk of Type 2 Diabetes Mellitus: New Prospective Cohort Study and Literature-Based Meta-Analysis. Lustig AJ, editor. PLoS ONE. 2014 Nov 12;9(11):e112483.
Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MSV, et al. Transesophageal Echocardiography in Cryptogenic Stroke and Patent Foramen Ovale: Analysis of Putative High-Risk Features From the Risk of Paradoxical Embolism Database. Circulation: Cardiovascular Imaging. 2014 Jan 1;7(1):125–31.
Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 Sep;384(9947):957–79.
Turner EL, Sweeting MJ, Lindfield RJ, DeAngelis D. Incidence estimation using a single cross-sectional age-specific prevalence survey with differential mortality. Statistics in Medicine. 2014 Feb 10;33(3):422–35.
Toni D, Di Angelantonio E, Di Mascio MT, Vinisko R, Bath PM, for the PRoFESS Study Group. Types of Stroke Recurrence in Patients with Ischemic Stroke: A Substudy from the PRoFESS Trial. International Journal of Stroke. 2014 Oct;9(7):873–8.
The Myocardial Infarction Genetics Consortium Investigators. Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease. New England Journal of Medicine. 2014 Nov 27;371(22):2072–82.
Thaler DE, Ruthazer R, Weimar C, Mas J-L, Serena J, Di Angelantonio E, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs. Neurology. 2014 Jul 15;83(3):221–6.
Thaler DE, Ruthazer R, Weimar C, Serena J, Mattle HP, Nedeltchev K, et al. Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke. Neurology. 2014 Nov 18;83(21):1954–7.
Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Injuries Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2014 Jul 3 [cited 2018 Jun 22]; Available from: http://doi.wiley.com/10.1002/14651858.CD009532.pub2